Today on DrugResearcher.com   Tamiflu waste could create drug resistant flu viruses PDL BioPharma for sale: one careful owner? BMS takeover speculation mounts, again Sperm stopped in their tracks by vaginal gel contraceptive Recordati adopts Orphan Europe

Related Industry News   SAFC bets on drug conjugates with new manufacturing suite Pharmaceutical manufacturing: people on the move Sprinkles help the medicine go down Drug theft costs industry up to $1bn a year

Breaking News on Drug Discovery
Daily  Wednesday 03 October 2007		Forward to a colleague

	Product Brochure Unique Process technology for drying very small quantities of API ProCepT's R&D Drying Technology for small quantities of API; SPRAY DRYING - NUTSCHE FILTER DRYING - AGITATED VACUUM DRYING - MICROWAVE DRYING. Fully instrumented and automated for Maximum of process knowledge with Minimum of API in a Minimum of time! Make use of the ProCepT lab... Click Here Access Full Stories Tamiflu waste could create drug resistant flu viruses The excessive use of a popular influenza drug, and the associated build up of its waste in the environment, is heightening the risk of creating viruses in nature that are resistance to the therapy... Read PDL BioPharma for sale: one careful owner? PDL BioPharma's board has decided to scrap its restructuring plan and put the tormented company for sale, giving in to recent shareholders' pressure... Read BMS takeover speculation mounts, again Investors in Bristol-Myers Squibb were in a frisson of excitement earlier this week as speculation mounted - not for the first time - that the firm could soon become the target of a major pharmaceutical acquisition... Read Sperm stopped in their tracks by vaginal gel contraceptive Forget diamonds, a new vaginal gel contraceptive could be the 21st Century girl's new best friend with the ability to be applied up to 18 hours before a naughty rendezvous... Read Recordati adopts Orphan Europe Eighty-year-old Italian pharma company Recordati believes its future lies in rare diseases and has put its money where its mouth is by spending €135m on speciality firm Orphan Europe... Read
	All News Headlines for: October | September | August
	Application Notes Separation of polar compounds A Mini-tutorial to HILIC The ZIC®-HILIC column is the ideal choice for separation of polar and hydrophilic compounds. Amino acids, bases, peptides, carbohydrates, plant extracts and other polar compounds have good retention on the column from SeQuant - "The Number One in HILIC"... Click Here
	Related Industry News SAFC bets on drug conjugates with new manufacturing suite SAFC has announced its plans to build a new high potency conjugation suite at its Missouri manufacturing plant in order to target pharma clients developing novel anti-cancer drug conjugates... Read Pharmaceutical manufacturing: people on the move Mylan, Momenta Pharmaceuticals, VaxGen, Osprey Pharmaceuticals, Bioject Medical Technologies, and Othera Pharmaceuticals have all had people on the move in the world of pharmaceutical manufacturing... Read Sprinkles help the medicine go down US regulators have found a new 'hundreds and thousands'-like drug treatment to be very palatable... Read Drug theft costs industry up to $1bn a year Pharmaceutical companies not only have to face the consequences of a burgeoning counterfeit drug black market but have to contend with the theft of their own manufactured drugs for illicit uses, according to a... Read Inside India: special series Clinical trials in India: 'The wind is blowing' An industry veteran gives Outsourcing-Pharma.com an update on the state of the contract research organisation (CRO) industry in India. Read Product Brochure A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here Previous Headlines 'In-house' outsourcing firm in line for EU accolade Synergy has been short-listed in three categories for the upcoming European Outsourcing Awards - an accolade that could give a boost to its innovative "in house" outsourcing model... Read BMS shows off cancer drug as it waits for regulator decision With a regulator decision looming ever closer, Bristol-Myers Squibb (BMS) has set out to woo European oncologists with its first-in-class breast cancer drug... Read FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials... Read Biogen antibody regenerates MS nerves Biogen Idec is pushing forward with a therapeutic antibody that can turn myelin producing cells back on and so could reverse the damaging effects of multiple sclerosis (MS)... Read ABI and Olink to push protein detection sensitivity Applied Biosystems (ABI) has exclusively licensed Olink Bioscience's proximity ligation assay (PLA) technology that enables the correlation of gene and protein expression data... Read Product Information - brochures, Web centers Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com